| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 132.33B | 188.01B | 239.15B | 270.75B | 295.95B |
| Gross Profit | 2.57B | -2.62B | 612.00M | -10.00B | 24.81B |
| EBITDA | -14.78B | -32.64B | -28.22B | -36.20B | 160.00M |
| Net Income | -19.81B | -78.22B | -44.31B | -25.82B | -8.10B |
Balance Sheet | |||||
| Total Assets | 124.25B | 148.03B | 223.99B | 222.70B | 258.27B |
| Cash, Cash Equivalents and Short-Term Investments | 27.75B | 21.07B | 29.34B | 26.22B | 52.25B |
| Total Debt | 65.00B | 59.50B | 33.50B | 0.00 | 73.68B |
| Total Liabilities | 131.66B | 141.14B | 138.33B | 98.26B | 185.50B |
| Stockholders Equity | -7.41B | 6.89B | 85.66B | 124.43B | 72.77B |
Cash Flow | |||||
| Free Cash Flow | -24.39B | -35.96B | -29.67B | -74.30B | -28.84B |
| Operating Cash Flow | -23.20B | -25.45B | -17.58B | -65.67B | -21.67B |
| Investing Cash Flow | 22.76B | -8.16B | -13.43B | 9.78B | 95.00M |
| Financing Cash Flow | 5.05B | 25.69B | 32.90B | 27.68B | 14.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥643.12B | 12.70 | ― | 2.18% | 3.12% | 2.74% | |
74 Outperform | ¥534.90B | 13.26 | 6.30% | 2.16% | 4.78% | ― | |
74 Outperform | ¥1.23T | 18.84 | 15.75% | 1.08% | 18.84% | 42.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥74.71B | 34.03 | 0.90% | 4.00% | -1.57% | -49.55% | |
46 Neutral | ¥28.79B | -197.75 | ― | ― | 0.95% | -257.77% | |
41 Neutral | ¥264.47B | -22.49 | -217.94% | ― | -29.62% | 86.43% |